Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Patient Information Leaflet last updated on the eMC: 03/10/2011
PIL Aptivus 100 mg/ml oral solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
Updated on 10/11/2010 and displayed until 03/10/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 15/01/2010 and displayed until 10/11/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 15/10/2009 and displayed until 15/01/2010
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   tipranavir